TAG's 2020 Pipeline Report: TB chapters released

Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.

Read More →

New survey finds millions of people affected by TB still diagnosed and treated with outdated tools

Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.

Read More →

First digital adherence technology in the GDF’s product catalog

Smart medication container included in Stop TB Partnership's Global Drug Facility (GDF) product catalog.

Read More →

SHINE trial on shorter treatment for children with minimal TB

TB treatment can be shortened from six to four months in 80% of children.

Read More →

Landmark TB trial identifies shorter-course treatment regimen

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

Read More →

Progress towards achieving global TB targets

UN Secretary-General outlines priority recommendations to accelerate the TB response and reach targets.

Read More →

WHO: Global TB progress at risk

Global TB Report 2020: Access to TB services remains a challenge; global targets for prevention and treatment will likely be missed without urgent action and investments.

Read More →

Policy brief: COVID-19 – the new reality of Ending Tuberculosis

A document, released by the TB Europe Coalition, in commemoration of the second anniversary of the signing of the UN Political Declaration on TB.

Read More →

TAG policy brief: Advancing Access through Market Interventions

Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down

Read More →

Public investment in bedaquiline up to five-fold that of Johnson & Johnson

PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.

Read More →

Page 1 of 107 · Total posts: 10

1 2 Last→

To subscribe to the Weekly Newsletter of new posts, enter your email here:

Learn About TB